# Curevo funding rounds and investors

As of 14 Oct 2026, Curevo has raised $110M across 1 verified round on record; latest: $110 million Series B led by Medicxi, announced 17 Mar 2025.

Curevo Inc. develops an adjuvanted subunit vaccine for the prevention of shingles in adults.

Website: https://curevovaccine.com  
Headquarters: near Seattle  
Page: https://fireround.dev/companies/curevovaccine.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-03-17 | Series B | $110 million | Medicxi | Adjuvant Capital, GC Biopharma, HBM Healthcare Investments, Janus Henderson Investors, OrbiMed, RA Capital Management, Sanofi Ventures | [globenewswire.com](https://www.globenewswire.com/news-release/2025/03/17/3043632/0/en/curevo-raises-110-million-to-advance-amezosvatein-shingles-vaccine.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.